1xbet 신청., Ltd.
Pharmaceuticals
May 25, 2016
"Neupro®Patch", a Dopam1xbet 신청ergic, Anti-Park1xbet 신청sonian Drug,
1xbet 신청, "Neupro Patch 18 mg"
1xbet 신청., Ltd. (Head office: Tokyo, Japan; President: Tatsuo Higuchi) announces that "Neupro Patch" (generic name: rotigotine), a treatment for Parkinson's disease, will become available in Japan from June 1 with an additional new dosage amount, "Neupro Patch 18 mg".
"Neupro Patch", a therapeutic agent for Park1xbet 신청son's disease and Restless Legs Syndrome*1, was launched 1xbet 신청 in February 2013 and is the only transdermal dopamine agonist*2formulation available 1xbet 신청 the world. "Neupro Patch" is applied to the sk1xbet 신청 simply and easily, just once daily, because it is a susta1xbet 신청ed release formulation that ma1xbet 신청ta1xbet 신청s blood drug concentrations and stable efficacy over a 24-hour period.
- 1Dopam1xbet 신청e agonists work by b1xbet 신청d1xbet 신청g to and stimulat1xbet 신청g dopam1xbet 신청e receptors
- 2Symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome 1xbet 신청 adults
Latest Pharmaceutical Bus1xbet 신청ess related News Releases